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1. Introduction 
Colicin E3 has been shown to kill sensitive bacteria 
by primarily inhibiting protein synthesis, without 
affecting other macromolecular synthesis or energy 
metabolism [ 1,2] . The effect of E3 on protein syn- 
thesis has been ascribed to a specific cleavage of 16 S 
ribosomal RNA [3,4] which inactivates 30 S sub- 
units, but does not affect the functional activity of 
50 S subunits [S] . Recently, a cell-free system has 
been developed in which incubation of 70 S ribosomes 
with E3 results in ribosome inactivation and 16 S RNA 
cleavage, an identical result with that in viva [6, 71. 
Experiments reported here show that both 50 S and 
30 S ribosomal subunits are required for inactivation 
in vitro, and that both subunits and E3 must be pres- 
ent simultaneously for the inactivation to occur. 
Independently, Boon has obtained similar results [8]. 
2. Materials and methods 
Ribosomes were obtained from E. coli strain Q13, 
and were purified by pelleting through 1 M NH4C1 in 
TMA I buffer (10e2 M Tris pH 7.6, 10e2 M MgC12, 
3 X 10e2 M NH,Cl, 6 X 10e3 M P-mercaptoethanol); 
70 S ribosomes were then isolated from lo-30% 
sucrose-TMA I gradients. 30 S and 50 S subunits were 
* This is paper No. 1527 of the Laboratory of Genetics and 
paper VII in the series, “Interaction of Colicins with Bac- 
terial Cells”. Paper V and VI in this series are [ 4) and [ 71, 
respectively. 
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isolated from the 70 S ribosomes by dissociation at 
3X 1O-4 MMg”, followed by centrifugation on 
similar sucrose gradients containing 3 X 1 0e4 M Mg’+. 
Most of the small membrane fragments usually found 
in “S-30” crude cell extracts were removed from the 
ribosomes by this purification procedure. The colicin 
E3 preparation used has been described previously 
[7] , Anti-E3 antiserum was obtained from a New 
Zealand white rabbit bled one week after the last of 6 
subcutaneous injections of 1.0 mg each of the E3 prep- 
aration emulsified in Freund’s Complete Adjuvant 
(Perrin’s modification, Calbiochem) administered over 
a 4-week period. IgG antibody was purified by column 
chromatography on DEAE-Sephadex [9] and then 
Sephadex G-200. Poly U-dependent polyphenyl- 
alanine synthesis under standard conditions [ 10, 111 
for 15 min at 37” was used as the measure of 
ribosome activity. 
3. Results and discussion 
Ribosomes were mixed with E3 or buffer as de- 
scribed in table 1, and were incubated at 37” for 30 
min. 5 ~1 aliquots of the reaction mixtures were re- 
moved and were immediately diluted 1 O-fold into cold 
TMA I buffer. Other components necessary for the 
activity assay were then added, making the final di- 
lution a total of 30-fold compared to the incubation 
mixture. No significant E3-induced ribosome inacti- 
vation occurred during the protein synthesis assay under 
these conditions. 
The results described in table 1 show that E3 does 
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Table 1 Table 2 
Inactivation of ribosomes by colicin E3 in vifro. Requirement of the simultaneous presence of 30 S and 50 S 
subunits and E3 for ribosome inactivation. 
Components in the 
incubation mixture 
Incorporation activity 
Preincubation conditions 
Ribosome E3 (cpm) (%) 
Tube no. 50 s 30 s 
70 s _ 
+ 
50 s 
+ 
30 s 
+ 
5os+3os - 
+ 
4687 100 
1509 32 
860* 100 
865 101 
1321* 100 
1035 78 
1376 100 
356 26 
1 + Buffer + Buffer 665 100 
2 +E3 + Buffer 50 a 
3 +E3 + Anti-E3 650 98 
4 + Buffer +E3 109 16 
5 + Anti-E3 +E3 707 106 
2.7 A2e0 units of 70 S, 1.8 Az60 units of 50 S or 0.9 A2s0 
units of 30 S ribosomal subunits were incubated at 37” in 
20 ~1 TMA I, in the presence or absence of 2 @g of colicin 
E3. 5 /.d samples were removed after 30 min and diluted for 
the protein synthesis assay. Samples lacking 30 S or 50 S sub- 
units were supplemented in the assay with 0.45 Aaee units 
of 50 S or 0.225 Aaeo units of 30 S subunits. 
* Since the supplemented 30 S subunits had not been heat 
activated, the 50 S subunit activity appears decreased. Later 
identical experiments using heated 30 S subunits gave appro- 
priately higher counts and identical conclusions. 
7.0 Aaeo units of 50 S and 3.5 Aaso units of 30 S subunits 
were separately preincubated in 50 ~1 TMA I buffer in the 
presence or absence of colicin E3 (2.5 fig) or purified anti- 
E3 y-globulin (100 gg). After preincubation for 30 
min at 37”, 10 rd of each of the indicated 30 S and 50 S sam- 
ples were combined as indicated and incubated at 37’ for an 
additional 60 min. 5 ~1 aliquots were used to assay incorpo- 
ration activity. 
not significantly inactivate 30 S subunits unless 50 S 
subunits are present. This result is of interest because 
E3 treatment causes inactivation of the 30 S subunit, 
but not the 50 S subunit [5-71; therefore, 50 S sub- 
units must somehow play a role in the inactivation of 
30 S subunits. Two alternative possibilities exist. The 
first is that E3 interacts with 50 S subunits and causes 
a stable alteration; the altered 50 S subunits then 
cleave the 16 S RNA of the 30 S subunits. The second 
possibility is that E3 induces 16 S RNA cleavage only 
in the presence of both subunits, possibly by inter- 
acting with a 30 S-50 S complex. 
In order to decide between these two alternatives, 
30 S and 50 S subunits were separately treated with 
E3 at 37” for 30 min (table 2). As in the experiment 
described in table 1, the controls showed that E3 
caused more than 70% inactivation when both sub- 
units were present together under identical conditions 
(data not shown). Thus, if the first possibility is cor- 
rect, the 50 S subunits incubated with E3 must have 
been altered during this incubation and would be able 
to inactivate 30 S subunits without E3. This was 
tested by then incubating such “activated” 50 S sub- 
units with 30 S subunits in the presence of a suffi- 
cient amount of purified anti-E3 y-globulin to stop 
further action of colicin E3 (tube no. 3 in table 2). 
No inactivation of 30 S subunits was observed after 
60 min (cf., tubes no..3 and 1). In the absence of the 
anti-E3 y-globulin, the inactivation of 30 S subunits 
occurred during the subsequent incubation (tube 
no. 2). Table 2 also shows that there is no inactiva- 
tion of 30 S subunits when treated with E3 in the 
absence of 50 S subunits (tube no. 5). This confirms 
the conclusion obtained from the experiment shown 
in table 1. In addition, the results show that in the 
absence of 50 S subunits E3 does not induce any 
stable alteration of 30 S subunit structure which later 
leads to inactivation in the presence of 50 S subunits. 
In separate experiments, it was shown that the anti- 
E3 y-globulin used in these experiments neutralizes 
E3 activity nearly completely under the experimental 
conditions used and has no effect on the protein syn- 
thesizing ability of ribosomes. 
These results show that 30 S and 50 S subunits and 
E3 must be present simultaneously for 30 S subunit 
inactivation to occur. The results rule out the oc- 
currence of any stable, E3-induced alteration of 
either subunit which would allow later 30 S subunit in- 
activation in the absence of the E3 molecule. 
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The present study supports the previous con- 
clusion that, in vivo, E3 inactivates 30 S ribosomal 
subunits by making direct contact with the ribo- 
somes inside the cell [6,7]. The general mechanism 
of action of colicins in vivo has been fully discussed 
in the previous paper of this series [7]. 
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